Mochi Health vs SkinnyRx: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Mochi Health beats SkinnyRx overall, scoring 7.7/10 vs 7.3/10. Mochi Health is more affordable at $178/mo vs $199/mo. Choose Mochi Health for users who want a tech-forward platform with app-based tracki. Choose SkinnyRx for users who want flexibility in compounded glp-1 medication fo.
A side-by-side comparison of Mochi Health and SkinnyRx covering pricing, scores, medication types, insurance, and more to help you decide.
Mochi Health
#20 of 47Tech-forward GLP-1 platform with a sleek app for tracking progress, medications, and provider communications.
Visit Mochi HealthSkinnyRx
#36 of 47Direct-to-consumer telehealth platform offering compounded GLP-1 medications across five formats — injectable and sublingual semaglutide, semaglutide tablets, and tirzepatide as either injectable or tablets. Operated by Lean Rx, Inc. (Sacramento, CA). Compounded only — does not prescribe brand-name Wegovy/Zepbound/Ozempic/Mounjaro. Cash-pay only with HSA/FSA accepted; does not bill insurance. 4,100+ Trustpilot reviews at 4.8 stars.
Visit SkinnyRx| Feature | Mochi Health | SkinnyRx |
|---|---|---|
| Our Score | 7.7/10 | 7.3/10 |
| Starting Price | $178/mo | $199/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a tech-forward platform with app-based tracking | Users who want flexibility in compounded GLP-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point |
| Ranking | #20 | #36 |
Pros & Cons Compared
Mochi Health
Pros
- +Flat $99/mo semaglutide at ALL dose levels — saves $100-200/mo vs competitors who charge more at higher doses
- +4 semaglutide formats: injection, oral tablet, oral drops, and microdose — the most delivery options of any platform
- +Registered dietitians included alongside physicians — not just medication, but nutritional support
- +Both compounded and brand-name medications available (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus)
Cons
- −Separate $79/mo membership fee makes the real cost ~$178/mo for semaglutide, not the advertised $99
- −No refunds for payments made over 30 days ago — limited consumer protection window
- −Relatively new company (founded 2022) with less track record than established platforms
SkinnyRx
Pros
- +Five medication formats — the broadest compounded-GLP-1 menu in DTC telehealth, including the rare oral tirzepatide tablet that almost no competitor offers
- +$199/mo entry price for both injectable and sublingual semaglutide is competitive in the mid-tier compounded segment
- +Fast onboarding: 5–10 minute online questionnaire, physician review in 24–48 hours, medication delivered in 3–7 business days with temperature-controlled shipping
- +4,100+ Trustpilot reviews at 4.8 stars — among the strongest aggregate social-proof signals in the GLP-1 telehealth category
Cons
- −No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded-only model limits patients who want or need an FDA-approved finished product
- −Limited public transparency: founders, executive team, medical director, and specific compounding-pharmacy partners are not named on the public site
- −Cash-pay only — does not bill commercial insurance, Medicare, or Medicaid (HSA/FSA payments accepted)
- −Independent reviews flag inconsistent customer-service responsiveness, which is a real concern for a medication that requires titration support and dose-adjustment dialogue
Our Verdict
Mochi Health edges out SkinnyRx with a score of 7.7/10 vs 7.3/10. If budget is your priority, Mochi Health starts at $178/mo compared to SkinnyRx's $199/mo. Choose Mochi Health if you want: users who want a tech-forward platform with app-based tracking. Choose SkinnyRx if you want: users who want flexibility in compounded glp-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point.